Efficacy and Safety From a Recombinant Folding Variant of Bet v 1

NCT00554983 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergy

Interventions

BIOLOGICAL: recombinant birch pollen allergen
BIOLOGICAL: placebo

Sponsor

Allergopharma GmbH & Co. KG